Suppr超能文献

全血与成分输血治疗大出血止血复苏:系统评价和荟萃分析方案。

Whole blood versus component therapy for haemostatic resuscitation of major bleeding: a protocol for a systematic review and meta-analysis.

机构信息

Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA

Department of Trauma Surgery, Penn State College of Medicine, Hershey, Pennsylvania, USA.

出版信息

BMJ Open. 2021 Oct 4;11(10):e043967. doi: 10.1136/bmjopen-2020-043967.

Abstract

INTRODUCTION

There is a renewed interest in the use of whole blood (WB) to manage patients with life-threatening bleeding. We aimed to estimate mortality and complications risk between WB and blood component therapy for haemostatic resuscitation of major bleeding.

METHODS

We will conduct a systematic review and meta-analysis of studies published between 1 January 1980 and 1 January 2020, identified from PubMed and Scopus databases. Population will be patients who require blood transfusion (traumatic operative, obstetric and gastrointestinal bleeding). Intervention is WB transfusion such as fresh WB (WB unit stored for less than 48 hours), leukoreduced modified WB (with platelets removed during filtration), warm fresh WB (stored warm at 22°C for up to 8 hours and then for a maximum of an additional 24 hours at 4°C). The primary outcomes will be the 24-hour and 30-day survival rates (in-hospital mortality). Comparator is blood component therapy (red blood cells, fresh-frozen plasma and platelets given together in a 1:1:1 unit ratio). The Cochrane risk of bias tool for randomised controlled trials and Risk Of Bias In Non-randomised Studies - of Interventions (ROBINS-I) for observation studies will be used to assess the risk of bias of included studies. We will use random-effects models for the pooling of studies. Interstudy heterogeneity will be assessed by the Cochran Q statistic, where p<0.10 will be considered statistically significant and quantified by I statistic, where I ≥50% will indicate substantial heterogeneity. We will perform subgroup and meta-regression analyses to assess geographical differences and other study-level factors explaining variations in the reported mortality risk. Results will be reported as risk ratios and their 95% CIs.

ETHICS AND DISSEMINATION

No ethics clearance is required as no primary data will be collected. The results will be presented at scientific conferences and published in a peer-reviewed journal.

摘要

简介

人们对使用全血(WB)来治疗有生命危险的出血患者重新产生了兴趣。我们旨在评估全血与血液成分治疗在大出血止血复苏中的死亡率和并发症风险。

方法

我们将对 1980 年 1 月 1 日至 2020 年 1 月 1 日期间发表在 PubMed 和 Scopus 数据库中的研究进行系统评价和荟萃分析。人群为需要输血的患者(创伤性手术、产科和胃肠道出血)。干预措施是 WB 输血,如新鲜 WB(储存时间少于 48 小时的 WB 单位)、白细胞减少的改良 WB(过滤时去除血小板)、温热的新鲜 WB(储存于 22°C 下长达 8 小时,然后在 4°C 下最多再储存 24 小时)。主要结局是 24 小时和 30 天生存率(院内死亡率)。对照组为血液成分治疗(以 1:1:1 的单位比例给予红细胞、新鲜冷冻血浆和血小板)。将使用随机对照试验的 Cochrane 偏倚风险工具和非随机干预研究的偏倚风险(ROBINS-I)来评估纳入研究的偏倚风险。我们将使用随机效应模型对研究进行汇总。通过 Cochran Q 统计量评估研究间异质性,p<0.10 将被认为具有统计学意义,并通过 I 统计量量化,其中 I≥50%将表示存在实质性异质性。我们将进行亚组和荟萃回归分析,以评估地理差异和其他研究水平因素对报告的死亡率风险变化的解释。结果将以风险比及其 95%CI 报告。

伦理和传播

由于不会收集原始数据,因此不需要伦理批准。结果将在科学会议上报告,并发表在同行评议的期刊上。

相似文献

2
Whole blood transfusion in the treatment of acute hemorrhage, a systematic review and meta-analysis.
J Trauma Acute Care Surg. 2023 Aug 1;95(2):256-266. doi: 10.1097/TA.0000000000004000. Epub 2023 May 1.
3
Emergency administration of fibrinogen concentrate for hemorrhage: A protocol for systematic review and meta-analysis.
Medicine (Baltimore). 2021 Mar 12;100(10):e25099. doi: 10.1097/MD.0000000000025099.
5
The use of whole blood in traumatic bleeding: a systematic review.
Intern Emerg Med. 2021 Jan;16(1):209-220. doi: 10.1007/s11739-020-02491-0. Epub 2020 Sep 15.
6
Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage.
Emerg Med J. 2020 Jun;37(6):370-378. doi: 10.1136/emermed-2019-209040. Epub 2020 May 6.
8
Pathogen-reduced platelets for the prevention of bleeding.
Cochrane Database Syst Rev. 2013 Mar 28(3):CD009072. doi: 10.1002/14651858.CD009072.pub2.
9
Platelet transfusion for neonates with thrombocytopaenia: protocol for a systematic review.
BMJ Open. 2020 Oct 16;10(10):e039132. doi: 10.1136/bmjopen-2020-039132.
10
Single Institution Trial Comparing Whole Blood vs Balanced Component Therapy: 50 Years Later.
J Am Coll Surg. 2021 Apr;232(4):433-442. doi: 10.1016/j.jamcollsurg.2020.12.006. Epub 2020 Dec 19.

引用本文的文献

本文引用的文献

1
Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta-analysis.
J Am Coll Emerg Physicians Open. 2020 May 29;1(4):633-641. doi: 10.1002/emp2.12089. eCollection 2020 Aug.
2
The use of whole blood in traumatic bleeding: a systematic review.
Intern Emerg Med. 2021 Jan;16(1):209-220. doi: 10.1007/s11739-020-02491-0. Epub 2020 Sep 15.
3
Whole blood transfusion versus component therapy in adult trauma patients with acute major haemorrhage.
Emerg Med J. 2020 Jun;37(6):370-378. doi: 10.1136/emermed-2019-209040. Epub 2020 May 6.
4
How to perform a meta-analysis with R: a practical tutorial.
Evid Based Ment Health. 2019 Nov;22(4):153-160. doi: 10.1136/ebmental-2019-300117. Epub 2019 Sep 28.
5
Whole blood for the acutely haemorrhaging civilian trauma patient: a novel idea or rediscovery?
Transfus Med. 2016 Dec;26(6):406-414. doi: 10.1111/tme.12329. Epub 2016 Jun 29.
6
Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients.
J Trauma Acute Care Surg. 2016 Jul;81(1):21-6. doi: 10.1097/TA.0000000000001100.
7
Whole blood for hemostatic resuscitation of major bleeding.
Transfusion. 2016 Apr;56 Suppl 2:S190-202. doi: 10.1111/trf.13491.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验